<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Your Questions Answered</title>
	<atom:link href="http://www.damienbove.com/free-strategic-review/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.damienbove.com</link>
	<description>Damien Bove Shares The Expertise</description>
	<lastBuildDate>Mon, 23 Jan 2012 10:28:05 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Guidline on Quality, Non-Clinical and Clinical Aspects of Live Recombinant Viral Vectored Vaccines &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-164</link>
		<dc:creator>Guidline on Quality, Non-Clinical and Clinical Aspects of Live Recombinant Viral Vectored Vaccines &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Fri, 19 Jun 2009 08:21:55 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-164</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Guest Article - The Fight Against Influenza &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-160</link>
		<dc:creator>Guest Article - The Fight Against Influenza &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Thu, 18 Jun 2009 13:05:43 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-160</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: FDA guidance - Q8(R1) Pharamceutical Development - submission contents and overall pharmaceutical development guidance. &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-150</link>
		<dc:creator>FDA guidance - Q8(R1) Pharamceutical Development - submission contents and overall pharmaceutical development guidance. &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Fri, 12 Jun 2009 15:13:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-150</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Technology Strategy Board - New Competitions &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-149</link>
		<dc:creator>Technology Strategy Board - New Competitions &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Thu, 11 Jun 2009 07:15:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-149</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Correction on N8 &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-148</link>
		<dc:creator>Correction on N8 &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Wed, 10 Jun 2009 18:54:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-148</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: N8, METRC, and an Associated Proof of Concept Fund &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-145</link>
		<dc:creator>N8, METRC, and an Associated Proof of Concept Fund &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Wed, 10 Jun 2009 07:35:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-145</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: IDA consultants Provides Regulatory Roadmap &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-142</link>
		<dc:creator>IDA consultants Provides Regulatory Roadmap &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Mon, 08 Jun 2009 07:22:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-142</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: New Manchester University Spin Out Fund &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-135</link>
		<dc:creator>New Manchester University Spin Out Fund &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Fri, 05 Jun 2009 13:12:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-135</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: EMEA publishes concept paper on the development of guidlines on the use of Pharmacogenomic Methodogologies in PK evaluation &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-133</link>
		<dc:creator>EMEA publishes concept paper on the development of guidlines on the use of Pharmacogenomic Methodogologies in PK evaluation &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Thu, 04 Jun 2009 15:20:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-133</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: EMEA issue draft guidance on plasma-derived medicinal products &#124; Drug Development Consultant and Regulatory Consultant</title>
		<link>http://www.damienbove.com/free-strategic-review/comment-page-1/#comment-129</link>
		<dc:creator>EMEA issue draft guidance on plasma-derived medicinal products &#124; Drug Development Consultant and Regulatory Consultant</dc:creator>
		<pubDate>Tue, 02 Jun 2009 10:10:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.damienbove.com/?page_id=183#comment-129</guid>
		<description>[...] Free Strategic Review     Search [...]</description>
		<content:encoded><![CDATA[<p>[...] Free Strategic Review     Search [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

